| Literature DB >> 35387318 |
Rasmus Gregersen1,2, Cathrine Fox Maule3, Henriette Husum Bak-Jensen2, Allan Linneberg3,4, Olav Wendelboe Nielsen4,5, Simon Francis Thomsen6, Christian S Meyhoff2,4,7, Kim Dalhoff4,8, Michael Krogsgaard4,9, Henrik Palm4,9, Hanne Christensen4,10, Celeste Porsbjerg4,11, Kristian Antonsen12, Jørgen Rungby2,4,13, Steen B Haugaard2,4,13, Janne Petersen3,14, Finn E Nielsen1,2.
Abstract
Purpose: To present a metropolitan cohort, Bispebjerg acute cohort (BAC), and compare patient characteristics and outcomes with patients from urban and rural hospitals in Denmark. Patients andEntities:
Keywords: Danish national registers; acute care; emergency medicine; epidemiology; registry-based research; urban-rural disparities
Year: 2022 PMID: 35387318 PMCID: PMC8979568 DOI: 10.2147/CLEP.S338149
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Figure 1Map of hospitals with acute functions in Denmark and related catchment areas.
Patient Characteristics at Each Acute Hospital Contact
| Exposure | Group | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | ||
| All | All | 224,904 (65.5%) | 852,544 (52.1%) | 943,862 (45.3%) | 118,296 (34.5%) | 783,610 (47.9%) | 1,140,204 (54.7%) |
| Age | <25 years | 21.1% | 18.8%a | 19.5% | 6.4% | 6.5% | 7.0% |
| 25–39 year | 34.2% | 27.5%a | 22.1%a | 13.9% | 20.4%a | 15.8%a | |
| 40–64 years | 29.2% | 33.5%a | 35.4%a | 30.5% | 28.3% | 28.3% | |
| 65–79 years | 10.3% | 13.6%a | 15.7%a | 28.8% | 27.7% | 29.3% | |
| ≥80 years | 5.2% | 6.6%a | 7.3%a | 20.5% | 17.1%a | 19.6% | |
| Age, median | 36 (26–54) | 42 (27–60) | 45 (28–63) | 64 (45–77) | 61 (38–75) | 64 (42–77) | |
| Sex | Female | 52.2% | 51.5% | 48.6% | 51.7% | 55.3% | 54.4% |
| CPR status | Temporary CPR | 4.4% | 1.9%a | 1.6%a | 1.5% | 0.9%a | 0.8%a |
| Charlson Comorbidity Index (CCI) | CCI: 0 | 85.5% | 84.6% | 85.3% | 57.4% | 60.1% | 61.1% |
| CCI: 1–2 | 11.6% | 12.4% | 11.7% | 28.5% | 27.1% | 25.8% | |
| CCI: 3+ | 2.8% | 3.0% | 3.0% | 14.1% | 12.9% | 13.1% | |
| Educational level | Missing, or no primary education | 4.4% | 2.9%a | 2.2%a | 5.2% | 3.2%a | 2.6%a |
| Primary or lower secondary (ISCED 0–2) | 25.3% | 30.9%a | 37.8%a | 30.9% | 32.8% | 40.9%a | |
| Upper secondary or post-secondary, non-tertiary (ISCED 3–4) | 33.9% | 38.2%a | 40.1%a | 34.6% | 37.1% | 37.6% | |
| Short-cycle tertiary or above (ISCED 5–8) | 36.4% | 28.0%a | 19.9%a | 29.3% | 26.9% | 18.9%a | |
| Personal income (quintile) | First quintile | 26.1% | 21.8%a | 21.2%a | 14.2% | 13.7% | 13.8% |
| Second quintile | 24.6% | 21.4%a | 22.4% | 30.8% | 27.1%a | 31.8% | |
| Third quintile | 18.6% | 20.5% | 22.6%a | 26.2% | 26.9% | 28.4% | |
| Fourth quintile | 15.6% | 18.2%a | 19.0%a | 14.6% | 17.4%a | 15.7% | |
| Fifth quintile | 14.9% | 18.0%a | 14.8% | 14.2% | 14.9% | 10.4%a | |
| Employment status | Student | 18.0% | 14.0%a | 12.5%a | 5.6% | 5.6% | 4.5%a |
| Active employment | 46.2% | 47.9% | 46.6% | 26.1% | 32.1%a | 28.1% | |
| Unemployment, sick leave, absence allowance, etc. | 10.5% | 9.0%a | 8.6%a | 9.9% | 8.0%a | 8.0%a | |
| Disability pension | 4.1% | 5.3%a | 6.6%a | 7.7% | 8.3% | 9.5%a | |
| Old age pension and early retirement benefit | 14.4% | 18.8%a | 21.6%a | 46.9% | 42.7% | 47.3% | |
| Unknown | 6.9% | 5.0%a | 4.0%a | 3.8% | 3.3%a | 2.7%a | |
| Civil status | Married | 24.7% | 36.3%a | 39.2%a | 30.6% | 42.8%a | 44.5%a |
| Unmarried | 57.0% | 44.8%a | 41.2%a | 32.5% | 28.2%a | 24.8%a | |
| Divorced | 12.3% | 12.1% | 12.1% | 20.8% | 14.8%a | 14.3%a | |
| Widowed | 4.6% | 6.0%a | 7.1%a | 15.4% | 13.8%a | 16.2% | |
| Missing | 1.4% | 0.8%a | 0.5%a | 0.8% | 0.5%a | 0.2%a | |
| Cohabitation status | Single, living alone | 34.8% | 30.6%a | 29.2%a | 50.8% | 36.7%a | 37.2%a |
| Single, living with at least one other person | 21.3% | 13.2%a | 10.1%a | 11.8% | 7.9%a | 6.4%a | |
| Couples, living with at least one other person | 42.5% | 55.4%a | 60.2%a | 36.6% | 54.9%a | 56.1%a | |
| Missing | 1.4% | 0.8%a | 0.5%a | 0.8% | 0.5%a | 0.2%a | |
Notes: aMarks a statistically significant relative difference of at least 10% at a 0.05 significance level compared to BAC.
Abbreviations: BAC, Bispebjerg acute cohort; ISCED, International Standard Classification of Education; RuC, rural cohort; UrC, urban cohort.
Proportions of Patients with Medication Prescriptions Prior to Each Acute Hospital Contact
| Medication | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | |
| Polypharmacy (5 or more drugs) | 18.7% | 23.0%a | 24.7%a | 49.6% | 46.7% | 52.1% |
| Hyperpolypharmacy (10 or more drugs) | 5.0% | 6.1%a | 7.0%a | 19.4% | 18.1% | 21.9%a |
| Analgesics | 17.1% | 22.0%a | 24.9%a | 38.3% | 38.1% | 41.9% |
| Antibacterials for systemic use | 26.5% | 26.7% | 22.3%a | 32.1% | 32.6% | 35.5% |
| Antithrombotic agents | 8.5% | 11.7%a | 13.1%a | 30.2% | 28.0% | 31.7% |
| Drugs for acid related disorders | 10.4% | 12.2%a | 13.5%a | 26.1% | 25.4% | 28.4% |
| Agents acting on the renin-angiotensin system | 8.3% | 11.6%a | 13.1%a | 23.0% | 22.3% | 24.5% |
| Lipid modifying agents | 7.4% | 10.6%a | 12.0%a | 20.4% | 20.5% | 22.9% |
| Diuretics | 5.4% | 7.1%a | 8.6%a | 20.4% | 19.4% | 22.8% |
| Psychoanaleptics | 8.7% | 10.0%a | 12.3%a | 16.3% | 15.7% | 18.8%a |
| Psycholeptics | 9.1% | 9.0% | 9.6% | 21.6% | 16.8%a | 18.4%a |
| Beta blocking agents | 5.4% | 7.0%a | 8.2%a | 18.7% | 17.4% | 20.7% |
| Drugs for obstructive airway diseases | 7.1% | 7.7% | 8.3%a | 16.1% | 13.9%a | 16.7% |
| Anti-inflammatory and antirheumatic products | 8.4% | 10.8%a | 11.9%a | 10.5% | 11.2% | 12.4%a |
| Calcium channel blockers | 4.6% | 5.9%a | 7.2%a | 12.9% | 12.1% | 13.9% |
| Sex hormones and modulators of the genital system | 12.1% | 11.5% | 11.0% | 8.7% | 7.6%a | 8.0% |
| Mineral supplements | 2.6% | 3.6%a | 4.5%a | 11.7% | 11.7% | 14.5%a |
Notes: aMarks a statistically significant relative difference of at least 10% at a 0.05 significance level compared to BAC.
Abbreviations: BAC, Bispebjerg acute cohort; RuC, rural cohort; UrC, urban cohort.
Hospital Contact Characteristics
| Exposure | Group | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | ||
| All | 224,904 (65.5%) | 852,544 (52.1%) | 943,862 (45.3%) | 118,296 (34.5%) | 783,610 (47.9%) | 1,140,204 (54.7%) | |
| Elective/planned first contact | 0.5% | 2.6%a | 6.2%a | 4.3% | 11.8%a | 9.5%a | |
| Time of day for first contact | 8:00 to 15:59 | 43.2% | 49.5%a | 54.4%a | 54.4% | 52.2% | 53.6% |
| 16:00 to 23:59 | 44.8% | 40.3%a | 36.8%a | 32.9% | 31.2% | 31.6% | |
| 0:00 to 7:59 | 12.0% | 10.2%a | 8.8%a | 12.7% | 16.6%a | 14.8%a | |
| Hospital contact beginning on Sat-Sun | 37.1% | 33.1%a | 29.9%a | 21.9% | 23.2% | 22.5% | |
| Hospital contact includes psychiatric contact | 0.2% | 0.2% | 0.2% | 1.8% | 1.4%a | 1.7% | |
| Number of transfers between somatic departments per hospital contact | No transfer | 97.6% | 93.1% | 90.4% | 40.3% | 39.9% | 42.1% |
| One transfer | 2.3% | 6.5%a | 9.0%a | 39.5% | 38.5% | 40.4% | |
| Two transfers | 0.1% | 0.4%a | 0.6%a | 12.7% | 13.9% | 13.1% | |
| Three or more transfers | 0.01% | 0.03%a | 0.1%a | 7.5% | 7.7% | 4.4%a | |
| Acute contact not in region of residence | 7.7% | 6.5%a | 6.8%a | 3.8% | 4.8%a | 3.7% | |
Notes: aMarks a statistically significant relative difference of at least 10% at a 0.05 significance level compared to BAC.
Abbreviations: BAC, Bispebjerg acute cohort; RuC, rural cohort; UrC, urban cohort.
Grouped Primary Diagnoses for Patients at Last Contact in a Hospital Contact
| Grouped Primary Diagnoses at Last Contact | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | |
| All | 224,904 (65.5%) | 852,544 (52.1%) | 943,862 (45.3%) | 118,296 (34.5%) | 783,610 (47.9%) | 1,140,204 (54.7%) |
| Infectious diseases | 19.8% | 14.1%a | 6.2%a | 19.1% | 15.4%a | 17.2%a |
| Neoplasms | 0.02% | 0.2%a | 0.1%a | 1.1% | 4.3%a | 2.0%a |
| Diseases of the blood and blood-forming organs and certain disorders involved in the immune system | 0.4% | 0.2%a | 0.2%a | 1.3% | 1.2% | 1.4% |
| Endocrine, nutritional and metabolic disorders | 0.4% | 0.3%a | 0.3%a | 3.9% | 2.7%a | 3.1%a |
| Mental and behavioral disorders | 0.4% | 0.3%a | 0.2%a | 0.7% | 0.5%a | 0.8%a |
| Diseases of the nervous system | 0.7% | 0.7% | 0.5%a | 6.1% | 4.6%a | 3.0%a |
| Diseases of the eyes, ears, mouth, throat, and skin | 2.9% | 3.2% | 1.2%a | 0.9% | 1.2%a | 0.7%a |
| Diseases of the heart and circulatory system | 1.0% | 1.3%a | 1.3%a | 11.6% | 9.3%a | 8.9%a |
| Diseases of the respiratory system | 0.9% | 0.6%a | 0.4%a | 5.4% | 4.3%a | 4.7%a |
| Diseases of the digestive system | 1.8% | 1.3%a | 0.9%a | 8.4% | 6.0%a | 7.0%a |
| Diseases of the musculoskeletal system and connective tissue | 4.4% | 4.1% | 3.1%a | 3.0% | 3.0% | 2.5%a |
| Diseases of the genitourinary system | 1.1% | 1.6%a | 0.6%a | 1.8% | 2.5%a | 2.5%a |
| Diseases in pregnancy, birth, and perinatal period | 0.1% | 1.0%a | 0.5%a | 0.1% | 9.6%a | 6.9%a |
| Poisoning, intoxications, substance use, and adverse effects of medications | 1.7% | 1.5%a | 1.0%a | 3.4% | 2.6%a | 3.1%a |
| Injury and certain other consequences of external causes | 40.0% | 43.8% | 60.7%a | 6.7% | 7.6% | 8.0%a |
| Symptoms and abnormal findings, not elsewhere classified | 13.5% | 13.2% | 9.2%a | 14.0% | 14.6% | 17.7%a |
| Factors influencing health status and contact with health services | 10.8% | 12.5%a | 13.6%a | 12.4% | 10.8%a | 10.4%a |
Notes: aMarks a statistically significant relative difference of at least 10% at a 0.05 significance level compared to BAC.
Abbreviations: BAC, Bispebjerg acute cohort; RuC, rural cohort; UrC, urban cohort.
Proportion of Abnormal Results for the First of Each Laboratory Tests
| Laboratory Tests | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | |
| Haemoglobin; B | 2604 (28.8%) | 26,105 (22.4%)a | 24,917 (24.2%)a | 35,491 (35.4%) | 211,822 (40.1%)a | 267,543 (38.5%) |
| Leukocytes; B | 4147 (44.0%) | 43,547 (37.7%)a | 42,233 (38.6%)a | 51,263 (51.1%) | 261,664 (51.4%) | 368,198 (52.6%) |
| Thrombocytes; B | 1005 (12.0%) | 11,202 (10.7%) | 10,965 (11.8%) | 15,856 (16.3%) | 95,572 (19.4%)a | 114,488 (17.6%) |
| Coagulation, tissue factor-induced; P | 858 (10.8%) | 8307 (7.9%)a | 9444 (11.3%) | 13,521 (14.6%) | 62,865 (13.5%) | 92,500 (15.1%) |
| Sodium ion; P | 1645 (18.8%) | 19,839 (17.8%) | 17,371 (17.3%) | 27,640 (27.6%) | 159,285 (31.1%)a | 200,465 (29.5%) |
| Potassium ion; P | 1352 (15.7%) | 15,675 (14.1%) | 16,092 (16.1%) | 20,190 (20.3%) | 111,135 (21.7%) | 152,652 (22.5%) |
| Creatinine; P | 2082 (23.6%) | 21,183 (19.1%)a | 18,504 (18.5%)a | 31,263 (31.3%) | 165,696 (32.3%) | 208,621 (30.6%) |
| eGFR | 1635 (18.6%) | 14,141 (14.0%)a | 14,126 (15.9%)a | 26,497 (26.6%) | 129,434 (26.1%) | 174,570 (26.4%) |
| Albumin; P | 2882 (39.3%) | 17,588 (17.7%)a | 17,058 (17.7%)a | 45,486 (48.3%) | 177,704 (37.2%)a | 259,493 (39.8%)a |
| Bilirubin; P | 1777 (26.9%) | 17,585 (17.5%)a | 15,277 (19.5%)a | 17,240 (24.4%) | 82,612 (19.3%)a | 97,868 (17.8%)a |
| Alanine transaminase; P | 765 (12.3%) | 11,576 (11.3%) | 10,124 (12.4%) | 7999 (16.3%) | 75,705 (16.6%) | 91,708 (16.0%) |
| Alkaline phosphatase; P | 968 (14.4%) | 12,848 (12.7%) | 11,737 (14.4%) | 16,288 (21.6%) | 103,284 (23.5%) | 135,321 (24.3%)a |
| Amylase; P | 413 (6.9%) | 4143 (6.6%) | 3812 (6.0%) | 7044 (12.3%) | 32,655 (10.8%)a | 53,349 (11.4%) |
| C-reactive protein; P | 2871 (29.8%) | 34,818 (31.4%) | 38,820 (36.8%)a | 45,176 (45.4%) | 256,250 (51.2%)a | 371,212 (53.8%)a |
| Glucose; P | 1794 (30.6%) | 23,751 (23.6%)a | 21,296 (23.4%)a | 28,236 (36.3%) | 154,102 (38.2%) | 207,825 (34.6%) |
| Hydrogen ion; P | 2359 (31.7%) | 6990 (29.8%) | 5182 (28.2%) | 9528 (50.1%) | 75,792 (44.3%)a | 95,794 (40.6%)a |
| Oxygen; P | 4822 (65.7%) | 11,308 (60.0%) | 7722 (64.3%) | 11,676 (61.8%) | 96,339 (62.4%) | 135,780 (72.9%)a |
| Carbon dioxide; P | 2240 (30.0%) | 7565 (29.5%) | 4998 (31.2%) | 9342 (43.6%) | 86,779 (41.0%) | 96,490 (36.9%)a |
| Base excess; P | 3093 (41.6%) | 4091 (24.9%)a | 3162 (29.1%)a | 9262 (48.8%) | 52,587 (42.0%)a | 79,578 (47.5%) |
| Lactate; P | 2216 (29.9%) | 4884 (20.8%)a | 3565 (22.8%)a | 6455 (33.6%) | 48,903 (29.9%)a | 56,689 (30.1%) |
| Leukocytes; U | 2666 (42.4%) | 569 (19.6%)a | 711 (14.8%)a | 10,373 (39.8%) | 1854 (13.3%)a | 5044 (5.1%)a |
| Nitrite; U | 446 (7.1%) | 474 (9.2%)a | 593 (8.5%) | 2914 (11.2%) | 2469 (12.4%) | 15,966 (10.5%) |
| Erythrocytes; U | 2664 (42.4%) | 536 (29.9%)a | 529 (14.0%)a | 10,018 (38.5%) | 1841 (19.5%)a | 5054 (7.4%)a |
| Leukocytes; Csf | 19 (9.0%)a | 20 (10.1%)a | 229 (88.4%) | 1766 (35.8%)a | 1713 (29.6%)a | |
Notes: aMarks a statistically significant relative difference of at least 10% at a 0.05 significance level compared to BAC.
Abbreviations: BAC, Bispebjerg acute cohort; B, blood; Csf, cerebrospinal fluid; P, plasma; U, urine; RuC, rural cohort; UrC, urban cohort.
Outcomes During and Following Hospital Contacts
| Outcomes | Visits | Hospitalizations | ||||
|---|---|---|---|---|---|---|
| BAC | UrC | RuC | BAC | UrC | RuC | |
| Length of stay for combined hospital contact in hours (Median [Q1-Q3]) | 2 (1–3) | 2 (1–4) | 2 (1–3) | 38 (14–119) | 50 (17–123) | 35 (13–101) |
| In-hospital mortality | 3057 (2.6%) | 23,291 (3.0%) | 29,776 (2.6%) | |||
| Cumulative incidence of 30-day mortality | 0.4% (0.4–0.4%) | 0.4% (0.4–0.4%) | 0.4% (0.4–0.5%) | 3.0% (2.9–3.1%) | 3.1% (3.0–3.1%) | 3.4% (3.3–3.4%) |
| Cumulative incidence of 30-day readmission | 6.1% (6.0–6.2%) | 6.0% (6.0–6.1%) | 5.4% (5.4–5.5%) | 20.5% (20.3–20.8%) | 17.3% (17.2–17.4%) | 17.5% (17.5–17.6%) |
Notes: There was no statistically significant relative difference of at least 10% at a 0.05 significance level for UrC or RuC compared to BAC on in-hospital mortality. Significance testing was not performed on outcomes after discharge.
Abbreviations: BAC, Bispebjerg acute cohort; RuC, rural cohort; UrC, urban cohort.